0 items

in your cart
$0.00

Drug Search > Cytarabine

Prescription Drug Search

Strengths available for Cytarabine vial:

Cytarabine vial 100mg
Cytarabine vial 500mg
Cytarabine vial 1000mg

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Cytarabine:

  • Antigua and Barbuda
  • Aruba
  • Bahrain
  • Belgium
  • Bermuda
  • Ecuador
  • European Union
  • Fiji
  • Finland
  • France
  • Greece
  • Guadeloupe
  • Guam
  • Guatemala
  • Honduras
  • Hungary
  • Iceland
  • India
  • Iraq
  • Japan
  • Korea, Republic of
  • Mauritius
  • Moldova, Republic of
  • Monaco
  • Netherlands
  • Netherlands Antilles
  • Nicaragua
  • Norway
  • Panama
  • Portugal
  • Seychelles
  • Sweden
  • Switzerland
  • United Arab Emirates
  • United Kingdom, UK
  • United States, US
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vietnam
View All Countries

Latest news releases on Cytarabine:

Bone Marrow Stromal Cells Modulate Mouse ENT1 Activity and Protect Leukemia Cells from Cytarabine Induced Apoptosis - Elites TV

Despite a high response rate to chemotherapy, the majority of patients with acute myeloid leukemia (AML) are destined to relapse due to residual disease in the bone marrow (BM). The tumor microenvironment is increasingly being recognized as a critical ...

Continued: Congress acts to ease shortages of vital drugs in FDA overhaul - Minneapolis Star Tribune

WASHINGTON - Axel Zirbes' doctor said his leukemia required cytarabine, a standard chemotherapy drug that attacks cancers of the white blood cells. But when the 5-year-old Crystal boy was ready for treatment, doctors told his parents that ...

Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3 - Seekingalpha.com

Sunesis will present the poster titled "VALOR, an adaptive design, pivotal phase III trial of vosaroxin or placebo in combination with cytarabine in first relapsed or refractory acute myeloid leukemia" at the 2012 American Society of Clinical Oncology ...

90% of Oncologists Experiencing Drug Shortages - Medscape News

The most frequently cited drug was doxorubicin; 70.5% of respondents reported its shortage. Cytarabine and methotrexate were the 2 other drugs most commonly identified as being in short supply; they were cited by 40.0% and 30.5% of respondents, respectively.

Sunesis Pharmaceuticals Reports First Quarter 2012 Financial Results and Highlights - msnbc.com

In March, patient dosing began in the Cardiff University sponsored Phase 2/3 randomized, controlled, multicenter LI-1 Trial, which is evaluating novel treatment regimens, including two regimens containing vosaroxin, against low dose cytarabine ...

10-Q: SUNESIS PHARMACEUTICALS INC - Marketwatch

In December 2010, we commenced enrollment of a Phase 3, multi-national, randomized, double-blind, placebo-controlled, pivotal trial of vosaroxin in combination with cytarabine in patients with relapsed or refractory AML, or the VALOR trial.

Sunesis Pharmaceuticals, Inc. Earnings Conference Call (Q1 2012) - Yahoo! Finance

in previously untreated elderly patients with acute myeloid leukemia (AML); a Phase 1b/2 clinical trial combining Voreloxin with cytarabine for the treatment of patients with relapsed/refractory AML; and a Phase 2 single agent clinical trial in platinum ...

Senate passes bill to speed up approval of key medicines - Inside Bay Area

Senators of both parties said they had received pleas for help from constituents affected by shortages of drugs such as cytarabine for leukemia, Doxil for ovarian cancer and methotrexate for various diseases. The Senate majority leader ...

Cyclacel Pharmaceuticals Inc. : Cyclacel Reports First Quarter 2012 Financial Results - 4-traders (press release)

In May 2012, announced completion of enrollment of the Phase 2 portion of the investigator-led, Phase 2/3 multicenter, randomized trial comparing sapacitabine to low dose cytarabine (the "Pick a Winner Programme / LI-1 Trial") in patients aged 60 years or ...

Cyclacel Pharmaceuticals Inc. : Cyclacel to Report New Sapacitabine Clinical Data at the American Society of Clinical Oncology Annual Meeting - 4-traders (press release)

Phase 2/3 study comparing sapacitabine to low dose cytarabine as front-line treatment of elderly patients with AML or high risk MDS unfit for intensive chemotherapy. Sapacitabine acts through a novel DNA single-strand breaking mechanism, leading to ...

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK